PIM
RGNX icon

Partner Investment Management’s Regenxbio RGNX Stock Holding History

Partner Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,856
Closed -$264K – 117
2018
Q1 		$264K Buy
8,856
+462
+6% +$13.4K 0.29% 72
2017
Q4 		$279K Buy
+8,394
New +$253K 0.32% 64
2017
Q3 		– Sell
-4,824
Closed -$95K – 97
2017
Q2 		$95K Sell
4,824
-11,453
-70% -$222K 0.13% 83
2017
Q1 		$314K Buy
16,277
+4,828
+42% +$93.1K 0.38% 72
2016
Q4 		$212K Buy
11,449
+5,323
+87% +$102K 0.28% 78
2016
Q3 		$86K Buy
+6,126
New +$67.6K 0.13% 82
2016
Q1 		– Sell
-2,466
Closed -$41K – 88
2015
Q4 		$41K Hold
2,466
– – 0.07% 63
2015
Q3 		$54K Buy
+2,466
New +$62.9K 0.08% 60

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Partner Investment Management's RGNX Position: Q2 2018 in Review

Partner Investment Management sold out of Regenxbio (RGNX) in Q2 2018, closing a stake of 8,856 shares — an estimated $264K sold.

Partner Investment Management first reported a position in RGNX in Q3 2015 and held it in 8 quarters. The position peaked at $314K in Q1 2017. 177 funds tracked by Wall St. Rank hold RGNX as of Q2 2018.

  • Partner Investment Management reported no remaining Regenxbio position as of Q2 2018 after selling out during the quarter.
  • Partner Investment Management sold 8,856 Regenxbio shares in Q2 2018, an estimated $264K.
  • Partner Investment Management first reported a position in Regenxbio in Q3 2015 and held it in 8 quarters.
  • Partner Investment Management's Regenxbio position peaked at $314K in Q1 2017.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.